Pharmaceutical Guidelines
Search

SOP for Training of GMP Personnel

Last reviewed 16 Oct 2026 · 6 min read

Contents
  1. Objective
  2. Scope and regulatory basis
  3. Responsibilities
  4. Procedure
  5. 1. Identify training needs
  6. 2. Induction and job-specific training
  7. 3. Trainers and delivery
  8. 4. Schedule, assess and follow up
  9. 5. Maintain training records
  10. Frequently asked questions
  11. Does every employee need identical GMP training?
  12. Must there be an internal list of approved trainers?
  13. Is a one-week reminder before training a GMP requirement?
  14. References

In short: This illustrative SOP helps a pharmaceutical site plan, deliver, assess and document training for employees whose duties can affect product quality. Training should fit the assigned work, be delivered by qualified personnel, and include a check of practical effectiveness where applicable; adapt all role assignments and schedules to the approved site quality system.

Objective

Set out an example process for identifying training needs, preparing employees for assigned duties, checking practical competence and keeping training records. This is a template, not an approved procedure for a particular site.

Scope and regulatory basis

For personnel within its scope, 21 CFR 211.25(a) requires education, training and experience sufficient for assigned functions. It also addresses training in the particular operations an employee performs and continuing CGMP training by qualified individuals with sufficient frequency to maintain familiarity with applicable requirements. EU GMP Part I, Chapter 2, §§2.10–2.11 (2014) covers personnel entering production, storage or control laboratories and others whose activities could affect product quality; it calls for training suited to assigned duties, continuing training, periodic assessment of practical effectiveness, approved training programmes and training records. (21 CFR 211.25(a), current eCFR; EU GMP Part I, Chapter 2, §§2.10–2.11 (2014))

WHO’s current guidance for pharmaceutical quality control laboratories says competence requirements should be documented by function and that personnel should have records of qualifications, training and experience (WHO TRS 1052, Annex 4, §§5.1–5.2, 2024). This guidance applies to QC laboratories; determine the applicable regulatory scope for other functions. (WHO TRS 1052, Annex 4 (2024))

Responsibilities

Example in-house criterion (not a pharmacopoeial requirement): The department head identifies role-specific needs and coordinates on-the-job training; Quality Assurance oversees the site programme and approved trainer list; Human Resources or a designated records owner maintains induction records. Assign these responsibilities according to the local organization chart and document-control process.

Procedure

1. Identify training needs

Example in-house criterion (not a pharmacopoeial requirement): Maintain a role-based training plan that identifies required GMP or quality-system topics, task-specific procedures, safety topics, retraining needs after relevant changes, and the records needed to show completion. Prioritize tasks according to their potential effect on product quality, and update the plan when duties change.

Match the depth of training to the person’s role and contact with product:

  • Personnel whose duties can affect product quality (production, storage, quality control laboratory, technical, maintenance and cleaning staff, and others whose activities could affect quality) must receive training suited to their assigned duties. EU GMP Part I, Chapter 2, §2.10 says the manufacturer should provide training for personnel whose duties take them into production and storage areas or into control laboratories, and for other personnel whose activities could affect product quality. §2.11 adds basic GMP and quality-system training for new recruits, training appropriate to assigned duties, continuing training with periodic assessment of practical effectiveness, approved programmes and records. 21 CFR 211.25(a) similarly ties training to the particular operations each employee performs.
  • Personnel working where contamination is a hazard (for example clean areas, or areas handling highly active, toxic, infectious or sensitising materials) should receive specific training (EU GMP Part I, Chapter 2, §2.12).
  • Visitors and untrained personnel should preferably not be taken into production and quality control areas. If unavoidable, give them information in advance, particularly on personal hygiene and the prescribed protective clothing, and supervise them closely (EU GMP Part I, Chapter 2, §2.13). A basic hygiene and safety induction is therefore appropriate for them, not the full role-based GMP programme.
  • Employees with no duties that can affect product quality need only the basic site induction (hygiene, entry rules, safety) appropriate to where they work.

The sources do not require an identical course for every employee or a tour of every department; any departmental familiarization visit is a site choice (example in-house practice).

2. Induction and job-specific training

Provide information and supervision appropriate to the employee’s assigned duties before the person performs the work independently. Training may include applicable GMP or GLP principles, current procedures, equipment, documentation, safety, and relevant quality-system responsibilities. For practical tasks, include supervised performance and an assessment suited to the activity.

Example in-house criterion (not a pharmacopoeial requirement): Use an induction checklist for local orientation and a separate checklist for on-the-job training, with each item tied to the employee’s role and current controlled procedure.

3. Trainers and delivery

Training must be conducted by qualified individuals where 21 CFR 211.25(a) applies. EU GMP Chapter 2 requires initial and continuing training appropriate to assigned duties and periodic assessment of its practical effectiveness. The cited provisions do not prescribe a universal internal-trainer list or approval workflow.

Example in-house criterion (not a pharmacopoeial requirement): Maintain a list of internal trainers, with documented subject knowledge, experience and authorization to deliver the assigned course. A department may use a qualified external trainer when appropriate and document the training evidence.

4. Schedule, assess and follow up

Record completion and assess whether employees can apply the training to their assigned work. Address gaps with further instruction, supervised practice or reassessment as appropriate. Revisit training after applicable procedure, equipment, role or regulatory changes.

Example in-house practice (for better training management, not a regulatory requirement): Quality Assurance sends a reminder one week before each scheduled training session. The cited regulations and guidance do not set this interval; sites may adjust or omit it.

Example in-house criterion (not a pharmacopoeial requirement): Record the training topic, controlled document or method version, trainer, trainee, date, delivery method, attendance, assessment outcome, follow-up action and authorization where applicable. Use attendance alone only where the approved programme determines it is adequate evidence for that training.

5. Maintain training records

EU GMP Part I, Chapter 2, §2.11 (2014) requires training records. For records that form part of batch-associated production, control or distribution documentation, retain them at least one year after the respective batch’s expiry under 21 CFR 211.180(a) where applicable. EU GMP Part I, Chapter 4, §4.11 (January 2011) requires batch documentation to be retained for one year after expiry or at least five years after QP certification, whichever is longer. Follow any longer retention period required by local law, contract or the marketing authorisation. For training records not associated with a batch, follow the applicable approved retention schedule. (EU GMP Part I, Chapter 4, §4.11 (January 2011); 21 CFR 211.180(a), current eCFR)

For specific laboratory competence, see the SOP for qualification of QC analysts and the analyst qualification SOP. Also see personnel good practices for pharmaceutical QC laboratories.

Frequently asked questions

Does every employee need identical GMP training?

No. Training follows assigned functions and work that can affect product quality (EU GMP Part I, Chapter 2, §§2.10–2.11; 21 CFR 211.25(a)). Visitors and untrained persons get advance information on hygiene and protective clothing and are closely supervised (§2.13); other roles get content suited to their duties. Define course content and assessment for each role under the relevant quality system.

Must there be an internal list of approved trainers?

The cited rules require qualified training personnel where applicable, but do not prescribe one specific internal list format. A site may document trainer competence and authorization as an example in-house criterion.

Is a one-week reminder before training a GMP requirement?

No. No such interval appears in the official sources cited here. The one-week QA reminder is an in-house practice for better training management; it is not a regulatory requirement.

References

  • U.S. Electronic Code of Federal Regulations, current as of 14 October 2026: 21 CFR §211.25(a), Personnel qualifications. Official eCFR text.
  • European Commission. EudraLex Volume 4, EU GMP Guide, Part I, Chapter 2: Personnel, §§2.10–2.13 (2014; effective 16 February 2014). Official chapter.
  • World Health Organization. WHO Good Practices for Pharmaceutical Quality Control Laboratories, WHO Technical Report Series No. 1052, Annex 4, §§5.1–5.2 (2024). Official WHO text.
  • European Commission. EudraLex Volume 4, EU GMP Guide, Part I, Chapter 4: Documentation, §4.11 (January 2011). Official chapter.
  • U.S. Electronic Code of Federal Regulations, current as of 14 October 2026: 21 CFR §211.180(a), General requirements for records. Official eCFR text.

Related articles